Labcorp Holdings LH Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Biopharma Laboratory Services | $3.16B+1.9% | $3.1B+0.8% | $3.07B+2.0% | $3.01B+2.7% | $2.93B+0.4% | |
| Diagnostics | $11.01B+1.2% | $10.88B+1.3% | $10.73B+2.1% | $10.52B+2.2% | $10.29B+1.5% | |
| Operating Income by Business | ||||||
| Biopharma Laboratory Services | $512.3M+2.8% | $498.5M+1.1% | $493.1M+2.3% | $481.8M+3.4% | $465.9M+1.5% | |
| Corporate Segment | -$466.4M+3.3% | -$482.2M+15.5% | -$570.6M+9.9% | -$633.2M+6.1% | -$674.3M-0.5% | |
| Diagnostics | $1.81B+1.8% | $1.78B+3.5% | $1.72B+3.8% | $1.66B+2.6% | $1.62B+0.6% | |
| Other Cost and Expense, Operating by Business | ||||||
| Biopharma Laboratory Services | $384.5M-0.1% | $384.8M-0.9% | $388.4M+3.7% | $374.6M+3.9% | $360.6M-2.0% | |
| Diagnostics | $1.8B+0.4% | $1.79B+1.1% | $1.77B+2.7% | $1.73B+3.0% | $1.68B+2.8% | |
| Accounts Receivable, before Allowance for Credit Loss by Business | ||||||
| Biopharma Laboratory Services | $3.1B+1.6% | $3.05B+2.1% | $2.99B— | —— | —— | |
| Diagnostics | $5.67B+2.0% | $5.56B+1.6% | $5.47B+1.4% | $5.4B+1.5% | $5.32B+2.7% | |
| Labor and Related Expense by Business | ||||||
| Biopharma Laboratory Services | $1.24B+1.6% | $1.22B+1.6% | $1.2B+1.8% | $1.18B+1.4% | $1.16B-0.1% | |
| Diagnostics | $4.75B+1.4% | $4.69B+1.0% | $4.64B+1.2% | $4.59B+1.8% | $4.51B+1.5% | |
| Supplies Expense by Business | ||||||
| Biopharma Laboratory Services | $488.9M+2.2% | $478.5M-1.1% | $483.6M+2.1% | $473.6M+5.4% | $449.5M+1.7% | |
| Diagnostics | $2.38B+1.1% | $2.36B+1.0% | $2.33B+2.2% | $2.28B+2.1% | $2.24B+1.2% | |
| Goodwill by Business | ||||||
| Biopharma Laboratory Services | $5.44B— | —— | —— | —— | —— | |
| Diagnostics | $21.54B— | —— | —— | —— | —— | |
| Depreciation by Business | ||||||
| Biopharma Laboratory Services | $116M0.0% | $116M-0.2% | $116.2M-2.1% | $118.7M-1.1% | $120M-2.1% | |
| Diagnostics | $260.9M+0.8% | $258.8M-1.4% | $262.6M+0.5% | $261.3M+0.9% | $259M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Labcorp Holdings break its business down?
- Labcorp Holdings (LH) reports revenue by business across 2 parts — Biopharma Laboratory Services and Diagnostics. Each is extracted from the segment footnotes and tracked over time.
- Where does Labcorp Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Labcorp Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
